Table 3.

Association between PFCC transition interventions and quality of life (N = 11)

Study/year/location	Significance	Direction and Magnitude	Comment
Courtney (2009) Australia	Significant	+	p < .001
Hanssen, T. A (2007) Norway	Non‐significant	−	No differences on quality of life scores between groups
Harrison, M. B. (2002) Canada	Significant	+	Heart failure quality of life p = .002
Holmes‐Rovner, M. (2008) United States	Non‐significant	−	p = .55
Jerant et al. (2003) United States	Non‐significant	−	p = .39
Naylor, M. D. (2004) United States	Significant	+	p < .05
Nucifora, G (2006) Italy	Non‐significant	−	p > .05
Boter (2004) Netherlands	Non‐significant	−	No statistically significant differences
Chow (2010) China	Significant	+	Kidney disease quality of life p = .01
Huang T.T. (2005) Taiwan	Significant	+	p < .05
Lainscak et al. (2013) Slovenia	Non‐significant	−	p = .774